<DOC>
	<DOCNO>NCT00812929</DOCNO>
	<brief_summary>This study intend determine dose response duration action GSK2190915 mild asthmatic adult subject experience exercise-induced bronchoconstriction .</brief_summary>
	<brief_title>A Clinical Trial Test Study Drug Volunteers Who Develop Asthma Following Exercise</brief_title>
	<detailed_description>This study intend determine dose response duration action GSK2190915 mild asthmatic adult subject experience exercise-induced bronchoconstriction . Subjects invite complete screening visit , time exercise induce bronchoconstriction must demonstrate , defined decrease 20-40 % FEV1 compare baseline immediately follow exercise challenge . Eligible subject complete randomize , double-blind , five-way crossover study . Subjects randomize single dose either 10 mg , 50 mg , 100 mg , 200 mg GSK2190915 , placebo treatment period . Each treatment period last 2 day include various assessment follow exercise challenge 2 , 9.5 , 24 hour post dose . A minimum 7 day washout treatment period require . Regardless subject completes prematurely withdraw study , follow visit complete 7-21 day follow last dose .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Males female age 18 55 year inclusive . Female subject must non childbearing potential include premenopausal female document hysterectomy double oophorectomy tubal ligation postmenopausal define 12 month spontaneous amenorrhea 6 month spontaneous amenorrhea serum FSH level &gt; 40 mIU/mL estradiol &lt; 40 pg/ml ( &lt; 140 pmol/L ) 6 week postsurgical bilateral oophorectomy without hysterectomy . Hormone replacement therapy ( HRT ) permit postmenopausal female . Male subject must agree use one protocol outline contraception method . This criterion must follow time first dose study medication 3 month administration last dose . Body weight great equal 50 kg Body mass index within range 18.535.0 kg/m2 inclusive . Prebronchodilator FEV1 &gt; 70 % predict screening . Exercise induced bronchoconstriction , defined 2040 % decrease FEV1 compare baseline immediately follow exercise challenge screening . Current nonsmoker use tobacco product 6month period precede screen visit pack history less equal 10 pack year [ number pack year = ( number cigarette per day/20 ) x number year smoke ] Has provide sign date write informed consent Is able understand comply protocol requirement , instruction protocolstated restriction . Chronic use inhale corticosteroid ( ICS ) treatment persistent asthma . Past present disease , judge investigator medical monitor , may affect outcome study subject 's safety . These disease include , limited , cardiovascular disease , malignancy , hepatic disease , gastrointestinal disease , renal disease , haematological disease , neurological disease , endocrine disease pulmonary disease ( exception asthma , include chronic bronchitis , emphysema , bronchiectasis pulmonary fibrosis ) . Treated diagnosed clinical depression within six month screen history significant psychiatric illness . Known history hypertension hypertensive screening , opinion Investigator , deem subject unfit complete exercise challenge . Hypertension screen define persistent systolic BP &gt; 150 mmHg diastolic BP &gt; 90mmHg . Known history gastrointestinal bleeding . Respiratory tract infection within 2 week prior first dose study medication . Asthma exacerbation require treatment oral corticosteroid : exacerbation within 4 week screen visit two exacerbation within 2 month screen visit admittance hospital asthma exacerbation within 6 month screen visit . History lifethreatening asthma , define asthma episode require intubation and/or associate hypercapnoea , respiratory arrest and/or hypoxic seizure . History alcohol/drug abuse dependence within 12 month study . Abuse alcohol define average weekly intake &gt; 14 drinks/week men &gt; 7 drinks/week woman . One drink equivalent ( 12 g alcohol ) = 5 ounce ( 150 ml ) wine 12 ounce ( 360 ml ) beer 1.5 ounce ( 45 ml ) 80 proof distil spirit . Use prescription nonprescription drug ( include CYP 3A4 inhibitor inducer , vitamin dietary herbal supplement ) , 14 day screen followup visit , unless opinion Investigator sponsor medication interfere study . Inhaled beta2 agonist acetaminophen ( 4 g per day ) treatment minor ailment , eg headache , permit . Hormone replacement therapy ( HRT ) also permit postmenopausal female . Unable washout follow protocol define prohibited medication within define time : Medication Exclusion Period Oral injectable corticosteroid No use within 5 week screen visit Inhaled , Intranasal topical steroid No use within 4 week screen visit Long act beta2 agonists No use within 48 hour exercise challenge dosing lung function test Short act beta2 agonists No use within 6 hour exercise challenge dosing lung function test Following exercise challenge screen visit , subject experience great 40 % fall FEV1 compare baseline . Following exercise challenge screen visit , subject able recover least 20 % baseline FEV1 follow administration short act beta2 agonist . Requires rescue medication lung function assessment complete follow exercise challenge screen Symptomatic hay fever screening predict symptomatic hayfever time exercise challenge , opinion Investigator , would interfere outcome study . Participation study new molecular entity previous 3 month 5 halflives ( whichever longer ) , participation study without new molecular entity previous month 5 halflives ( whichever longer ) , prior first dose study medication . Undergoing allergen desensitisation therapy . There risk subject noncompliance study procedure . History blood donation ( 500 mL ) within 2 month start clinical study . A screen QTc value &gt; 450msec , PR interval outside range 120 220msec ECG suitable QT measurement ( e.g . poorly define termination Twave ) . Positive pregnancy test female . Positive test hepatitis C antibody hepatitis B surface antigen . Positive test HIV antibody . Positive prestudy urine cotinine/ breath carbon monoxide test urine drug/urine alcohol screen . A minimum list drug screen include Amphetamines , Barbiturates , Cocaine , Opiates , Cannabinoids Benzodiazepines . Has affiliation Investigative Site . Participation site personnel , spouse child , allow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Asthma , Exercise Induced Asthma , Exercise Induced Bronchospasm</keyword>
</DOC>